Scientists discovered a new way to protect memory in Alzheimer's by targeting the blood-brain barrier instead of amyloid ...

The US FDA has approved the first blood test to detect Alzheimer's disease in its early stages. This advancement promises ...

Researchers have found that the herpes virus, which causes cold sores, increases Alzheimer’s risk by as much as 80% by ...

Sanofi has announced that it will be acquiring Vigil Neuroscience and its investigational Alzheimer’s disease (AD) drug for ...

Already a Vigil Neuroscience investor, Sanofi has agreed to buy the rest of the biotech’s shares for $8 apiece, representing ...

TREATING cold sores with anti-viral medicines could slash the risk of Alzheimer’s disease by 17 per cent, research suggests. Previous studies have found that the herpes simplex virus – ...

EMA’s reluctance in approving drugs for the condition underscores Europe’s prioritisation of long-term safety over rapid ...

A world-first brain scanning technique could identify signs of Alzheimer’s disease long before symptoms appear. The method, ...

New research studying records of over 300,000 people suggests a link between herpes simplex virus-1 infection and Alzheimer's ...

HSV-1 infection may be linked to the risk for Alzheimer’s disease, but antiviral treatment may be protective, a large ...